Losartan Potassium
Product Images NDC 76519-1148

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 76519-1148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (76519 1033 Ppac Label)

Label (76519 1033 Ppac Label)
This is a label text of Losartan Potassium 100mg Tab, a prescription medicine which should only be taken as directed by a physician. It is prohibited by the Federal Law to transfer the drug to anyone other than the person it is prescribed to. It should be kept out of reach of children and stored at temperatures between 68-77°F. The medicine compares with another called Gozaat. The label includes the manufacturer's name, expiration date, lot number, and account number. The manufacturer's National Drug Code is also present. The label is from Camber Pharma and it also includes the name of a company called H.J. Harkin Co. located in Grover Beach, CA 03433.*
FDA Label Image

76519 1148 Ppac Label

76519 1148 Ppac Label
This is a medication label for Losartan Potassium 25mg tablets. The label contains important cautionary information, which includes not transferring the medication to anyone other than the person for whom it is prescribed and only dispensing it with a valid prescription, unless it is available over the counter. The label also specifies that the medication should be kept out of reach of children and stored at temperatures between 66-77°F. The medication is manufactured by a company called Mig. Gamber Pharma and packaged by Ropack: H.J. Harkin Co., Inc. The label also contains information regarding the medication's expiration date, lot number, and manufacturing NDC (national drug code). The medication should be used as directed by a physician.*
FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
The given text provides information about the adjusted risk reduction of a study in percentage and its statistical significance (p-value). It also includes a graph showing the percentage of patients with first-line or fatal stroke over a period of 66 months. No further information is available.*
FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

Figure4 (Figure4)
This text is providing information about the percentage of patents with an event related to risk reduction, which is 18.1% (0022). It also mentions the time period, which is expressed in months.*
FDA Label Image

Image (Image)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.